Nicotinic acetylcholine receptors as targets for antidepressants

RD Shytle, AA Silver, RJ Lukas, MB Newman… - Molecular …, 2002 - nature.com
While the monoamine deficiency hypothesis of depression is still most commonly used to
explain the actions of antidepressant drugs, a growing body of evidence has accumulated …

Mecamylamine–a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders

I Bacher, B Wu, DR Shytle… - Expert opinion on …, 2009 - Taylor & Francis
Mecamylamine (Inversine®), the first orally available antihypertensive agent launched in the
1950s, is rarely used today for hypertension because of its widespread ganglionic side …

Purinergic signalling in endocrine organs

G Burnstock - Purinergic signalling, 2014 - Springer
There is widespread involvement of purinergic signalling in endocrine biology. Pituitary cells
express P1, P2X and P2Y receptor subtypes to mediate hormone release. Adenosine 5 …

What we have gained from ibogaine: α3β4 nicotinic acetylcholine receptor inhibitors as treatments for substance use disorders

CJ Straub, LE Rusali, KM Kremiller… - Journal of medicinal …, 2022 - ACS Publications
For decades, ibogaine─ the main psychoactive alkaloid found in Tabernanthe iboga─ has
been investigated as a possible treatment for substance use disorders (SUDs) due to its …

Molecular biology and electrophysiology of neuronal nicotinic receptors of rat chromaffin cells

S Di Angelantonio, C Matteoni… - European Journal of …, 2003 - Wiley Online Library
Neuronal nicotinic acetylcholine receptors of chromaffin cells in the adrenal medulla are
physiologically activated by acetylcholine to mediate catecholamine release into the …

Region-specific effects of nicotine on brain activity: a pharmacological MRI study in the drug-naive rat

A Gozzi, A Schwarz, T Reese, S Bertani… - …, 2006 - nature.com
We have applied pharmacological magnetic resonance imaging (phMRI) methods to map
the functional response to nicotine in drug-naïve rats. Nicotine (0.35 mg/kg intravenous (iv)) …

Chemokines (CCL3, CCL4, and CCL5) Inhibit ATP‐Induced Release of IL‐1β by Monocytic Cells

AL Amati, A Zakrzewicz, R Siebers… - Mediators of …, 2017 - Wiley Online Library
Chemokines and ATP are among the mediators of inflammatory sites that can enter the
circulation via damaged blood vessels. The main function of chemokines is leukocyte …

Nicotine-induced dystonic arousal complex in a mouse line harboring a human autosomal-dominant nocturnal frontal lobe epilepsy mutation

Y Teper, D Whyte, E Cahir, HA Lester… - Journal of …, 2007 - Soc Neuroscience
We generated a mouse line harboring an autosomal-dominant nocturnal frontal lobe
epilepsy (ADNFLE) mutation: the α4 nicotinic receptor S248F knock-in strain. In this mouse …

Quantitative assessment of oligomeric amyloid β peptide binding to α7 nicotinic receptor

E Cecon, J Dam, M Luka, C Gautier… - British journal of …, 2019 - Wiley Online Library
Background and Purpose Progressive dysfunction of cholinergic transmission is a well‐
known characteristic of Alzheimer's disease (AD). Amyloid β (Aβ) peptide oligomers are …

Nicotine attenuates activation of tissue resident macrophages in the mouse stomach through the β2 nicotinic acetylcholine receptor

A Nemethova, K Michel, PJ Gomez-Pinilla… - PLoS …, 2013 - journals.plos.org
Background The cholinergic anti-inflammatory pathway is an endogenous mechanism by
which the autonomic nervous system attenuates macrophage activation via nicotinic …